bioAffinity Technologies, Inc.
BIAF
$0.3535
-$0.0115-3.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.74M | -9.04M | -8.45M | -8.74M | -8.37M |
| Total Depreciation and Amortization | 610.60K | 605.60K | 600.80K | 507.10K | 377.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.03M | 989.70K | 990.10K | 990.80K | 874.90K |
| Change in Net Operating Assets | 1.53M | 179.70K | -348.70K | 211.10K | 258.90K |
| Cash from Operations | -6.56M | -7.26M | -7.20M | -7.03M | -6.85M |
| Capital Expenditure | -88.50K | -79.10K | -65.70K | -56.50K | -32.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | -2.19M | -2.19M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -88.50K | -79.10K | -65.70K | -2.24M | -2.22M |
| Total Debt Issued | 164.10K | 191.80K | 288.70K | 26.80K | 27.70K |
| Total Debt Repaid | -411.60K | -361.10K | -354.90K | -314.70K | -350.40K |
| Issuance of Common Stock | 4.89M | 6.29M | 4.08M | 2.57M | 2.57M |
| Repurchase of Common Stock | -494.90K | -494.90K | -494.90K | -494.90K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 495.00K | 0.00 | 0.00 | 0.00 | -495.00K |
| Cash from Financing | 4.64M | 5.63M | 3.52M | 1.79M | 1.76M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.01M | -1.72M | -3.75M | -7.48M | -7.32M |